These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10712412)

  • 1. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1.
    Sjöland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):846-52. PubMed ID: 10712412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.
    Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
    Blood; 2000 Dec; 96(13):4212-5. PubMed ID: 11110693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
    Zhu Y; Farrehi PM; Fay WP
    Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
    Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE
    J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.
    Bonthu S; Heistad DD; Chappell DA; Lamping KG; Faraci FM
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2333-40. PubMed ID: 9409199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.
    Schafer K; Müller K; Hecke A; Mounier E; Goebel J; Loskutoff DJ; Konstantinides S
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2097-103. PubMed ID: 14512369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.
    Luttun A; Lupu F; Storkebaum E; Hoylaerts MF; Moons L; Crawley J; Bono F; Poole AR; Tipping P; Herbert JM; Collen D; Carmeliet P
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):499-505. PubMed ID: 11884297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.
    Han SG; Howatt DA; Daugherty A; Gairola CG
    Toxicology; 2012 Sep; 299(2-3):133-8. PubMed ID: 22659316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
    Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
    J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
    Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M
    Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
    Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
    Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
    Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice.
    Zibara K; Chignier E; Covacho C; Poston R; Canard G; Hardy P; McGregor J
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2288-96. PubMed ID: 11031217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.
    Ploplis VA; Cornelissen I; Sandoval-Cooper MJ; Weeks L; Noria FA; Castellino FJ
    Am J Pathol; 2001 Jan; 158(1):107-17. PubMed ID: 11141484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice.
    von der Thüsen JH; van Berkel TJ; Biessen EA
    Circulation; 2001 Feb; 103(8):1164-70. PubMed ID: 11222482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area.
    Tacken PJ; Delsing DJ; Gijbels MJ; Quax PH; Havekes LM; Hofker MH; van Dijk KW
    Atherosclerosis; 2002 May; 162(1):103-10. PubMed ID: 11947903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.